Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€8.35

€8.35

-2.340%
-0.2
-2.340%
-

-

 
29.04.24 / Stuttgart Stock Exchange WKN: A1137V / Name: Theravance / Stock / Pharmaceuticals / Small Cap /

Theravance Biopharma Stock

A loss of -2.340% shows a downward development for Theravance Biopharma.

Pros and Cons of Theravance Biopharma in the next few years

Pros
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Theravance Biopharma vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Theravance Biopharma -2.340% -1.724% 3.636% -10.938% -16.176% -47.866% -
Gritstone Oncology Inc -0.330% 7.643% -69.182% -65.035% -59.446% -90.086% -
Avid Bioservices Inc 3.650% 14.167% 7.031% -56.090% 12.295% -61.732% 61.082%
Pacira Pharmaceuticals - 0.840% -8.397% -39.698% -19.463% -53.398% -31.818%